Paul G Thomas

Title: Paul G Thomas: Innovator in T-Cell and Viral Infection Research

Introduction

Paul G Thomas is a notable inventor based in Memphis, TN (US). He has made significant contributions to the fields of immunology and virology through his innovative research and patented inventions. With a total of 3 patents, Thomas has focused on advancing methods for cloning T-cell receptors and treating viral infections.

Latest Patents

One of his latest patents is titled "Cloning and expression system for T-cell receptors." This invention provides a method for rapid cloning of T-cell receptors (TCRs) and B-cell receptors (BCRs) from single cells using CDR3 substitution, single cell PCR products, and Gibson Assembly techniques. The patent also includes a pre-generated TCR or BCR library in an expression vector. Another significant patent is "Coordinated metabolic reprogramming in response to productive viral infections." This invention relates to methods of treating viral infections using known drugs and pharmaceutical compositions, specifically targeting enveloped viruses.

Career Highlights

Paul G Thomas is currently affiliated with St. Jude Children's Research Hospital, where he continues to contribute to groundbreaking research in his field. His work has been instrumental in developing innovative solutions for complex medical challenges.

Collaborations

Thomas has collaborated with notable colleagues, including Heather S Smallwood and Marie Morfouace, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Paul G Thomas stands out as an influential inventor whose work in T-cell receptor cloning and viral infection treatment has the potential to significantly advance medical science. His contributions reflect a commitment to innovation and improving health outcomes.